Notes | 2024 $ ’000 | 2023 $ ’000 | |
Assets | |||
Investments | |||
Financial investments | 11 | ||
Deposits with ceding undertakings | | ||
Reinsurers' share of technical provisions | |||
Provision for unearned premiums | 5 | ||
Claims outstanding | 5 | ||
Debtors | |||
Debtors arising out of direct insurance operations | 12 | ||
Debtors arising out of reinsurance operations | 13 | ||
Other debtors | 14 | | |
Other assets | |||
Cash at bank and in hand | 17 | ||
Other | |||
Prepayments and accrued income | |||
Deferred acquisition costs | 5 | ||
Other prepayments and accrued income | | ||
Total assets |
Notes | 2024 $ ’000 | 2023 $ ’000 | |
Members’ balance and liabilities | |||
Capital and reserves | |||
Members’ balances | ( | ||
Technical provisions | |||
Provision for unearned premiums | 5 | ||
Claims outstanding | 5 | ||
Creditors | |||
Creditors arising out of direct insurance operations | 15 | ||
Creditors arising out of reinsurance operations | 16 | ||
Amounts owed to credit institutions | | ||
Other creditors including taxation and social security | | ||
Accruals and deferred income | |||
Total liabilities | |||
Total liabilities, capital and reserves |
2024 $’000 | 2023 $’000 | |
Members’ balances brought forward at 1 January | ( | ( |
Total comprehensive income/(loss) for the year | ( | |
Payments of profit to members’ personal reserve funds | ||
Losses collected on closure of underwriting year | ||
Cash calls on open underwriting years | ||
Members agent fees | ( | ( |
Net movement on funds in syndicate | ||
Other | ||
Members’ balances carried forward at 31 December | ( |
Notes | 2024 $ ’000 | 2023 $ ’000 | |
Cash flows from operating activities | |||
Profit/(loss) for the financial year | ( | ||
Adjustments: | |||
Increase/(decrease) in gross technical provisions | ( | ||
(Increase)/decrease in reinsurers’ share of technical provisions | |||
(Increase)/decrease in debtors | ( | ||
Increase/(decrease) in creditors | |||
(Increase)/decrease in deposits received from reinsurers | |||
Movement in other assets/liabilities | ( | ||
Foreign exchange | |||
Investment return | ( | ( | |
Net cash flows from operating activities | |||
Cash flows from investing activities | |||
Purchase of equity and debt instruments | ( | ( | |
Sale of equity and debt instruments | |||
Investment income received | |||
Net cash flows from investing activities | ( | ||
Cash flows from financing activities | |||
Distribution of profit | | ||
Collection of losses / Open Year Profit Release | |||
Injection/(release) of Funds in Syndicate | | ||
Other | ( | ( | |
Net cash flows from financing activities | |||
Net increase/(decrease) in cash and cash equivalents | |||
Cash and cash equivalents at the beginning of the year | |||
Foreign exchange on cash and cash equivalents | | ||
Cash and cash equivalents at the end of the year |